Alamar Biosciences, Inc. (ALMR)

NASDAQ: ALMR · Real-Time Price · USD

30.69

+0.97 (3.26%)

At close: Oct 23, 2026, 4:00 PM EDT

30.63

-0.06 (-0.20%)

After-hours: Oct 23, 2026, 7:42 PM EDT

Alamar Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	100.42	74.21	25.14
Revenue Growth	-	195.17%	-
Gross Profit	58.91	41.71	8.61
Operating Income	-40.74	-31.33	-49.57
Net Income	-49.66	-29.82	-46.27
Earnings Per Share	-2.10	-2.59	-4.60
EPS Growth	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
United States	60.99	45.42	14.55
Asia-Pacific	8.14	5.82	0.49
Europe, Middle East and Africa (Excluding Germany)	-	14.12	5.65
Germany	-	8.31	4.42
Rest of The World	-	0.54	0.03
Total	100.42	74.21	25.14

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	250.05	30	79.36
Total Debt	51.41	41.47	33.1
Net Cash (Debt)	198.65	-11.47	46.26
Net Cash Growth	-	-	-
Net Cash Per Share	8.39	-0.99	3.89

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-60.33	-53.61	-55.21
Capital Expenditures	-8.31	-5.37	-2.95
Free Cash Flow	-68.64	-58.98	-58.16
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	58.66%	56.20%	34.23%
Operating Margin	-40.57%	-42.22%	-197.15%
Pretax Margin	-48.42%	-39.29%	-187.18%
Profit Margin	-49.45%	-40.18%	-184.03%
FCF Margin	-68.35%	-79.48%	-231.33%